CN103127463B - External Chinese medicine preparation for phlebophlogosis - Google Patents
External Chinese medicine preparation for phlebophlogosis Download PDFInfo
- Publication number
- CN103127463B CN103127463B CN201310074393.6A CN201310074393A CN103127463B CN 103127463 B CN103127463 B CN 103127463B CN 201310074393 A CN201310074393 A CN 201310074393A CN 103127463 B CN103127463 B CN 103127463B
- Authority
- CN
- China
- Prior art keywords
- radix
- rhizoma
- parts
- chinese medicine
- curcumae
- Prior art date
Links
- 239000003814 drugs Substances 0.000 title claims abstract description 54
- 241000218176 Corydalis Species 0.000 claims abstract description 39
- 239000004863 Frankincense Substances 0.000 claims abstract description 21
- 208000001297 Phlebitis Diseases 0.000 claims description 37
- 241000628997 Flos Species 0.000 claims description 31
- 229940079593 drugs Drugs 0.000 claims description 23
- 239000002994 raw materials Substances 0.000 claims description 22
- 241001057584 Myrrha Species 0.000 claims description 20
- 210000000582 Semen Anatomy 0.000 claims description 20
- 235000003143 Panax notoginseng Nutrition 0.000 claims description 18
- 241000180649 Panax notoginseng Species 0.000 claims description 18
- 241001649190 Campsis Species 0.000 claims description 12
- 230000000694 effects Effects 0.000 abstract description 15
- 229920000742 Cotton Polymers 0.000 abstract description 2
- 239000000463 materials Substances 0.000 abstract description 2
- 241000427159 Achyranthes Species 0.000 abstract 1
- 244000144730 Amygdalus persica Species 0.000 abstract 1
- 241000382455 Angelica sinensis Species 0.000 abstract 1
- 235000003717 Boswellia sacra Nutrition 0.000 abstract 1
- 240000007551 Boswellia serrata Species 0.000 abstract 1
- 235000012035 Boswellia serrata Nutrition 0.000 abstract 1
- 240000007311 Commiphora myrrha Species 0.000 abstract 1
- 235000006965 Commiphora myrrha Nutrition 0.000 abstract 1
- 235000014375 Curcuma Nutrition 0.000 abstract 1
- 240000002123 Curcuma aromatica Species 0.000 abstract 1
- 240000009138 Curcuma zedoaria Species 0.000 abstract 1
- 235000003405 Curcuma zedoaria Nutrition 0.000 abstract 1
- 241000112528 Ligusticum striatum Species 0.000 abstract 1
- 235000007265 Myrrhis odorata Nutrition 0.000 abstract 1
- 240000008259 Paeonia officinalis Species 0.000 abstract 1
- 235000006484 Paeonia officinalis Nutrition 0.000 abstract 1
- 240000004678 Panax pseudoginseng Species 0.000 abstract 1
- 235000003181 Panax pseudoginseng Nutrition 0.000 abstract 1
- 235000006040 Prunus persica var persica Nutrition 0.000 abstract 1
- 235000017276 Salvia Nutrition 0.000 abstract 1
- 240000007164 Salvia officinalis Species 0.000 abstract 1
- 244000178320 Vaccaria pyramidata Species 0.000 abstract 1
- 235000010587 Vaccaria pyramidata Nutrition 0.000 abstract 1
- 239000001812 curcuma zedoaria berg. rosc. Substances 0.000 abstract 1
- 231100000486 side effect Toxicity 0.000 abstract 1
- 235000019509 white turmeric Nutrition 0.000 abstract 1
- 230000001225 therapeutic Effects 0.000 description 5
- 238000002560 therapeutic procedure Methods 0.000 description 5
- 239000011901 water Substances 0.000 description 5
- 201000010099 diseases Diseases 0.000 description 4
- 230000003203 everyday Effects 0.000 description 4
- 231100000957 no side effects Toxicity 0.000 description 4
- 208000007536 Thrombosis Diseases 0.000 description 3
- 238000000034 methods Methods 0.000 description 3
- 210000004369 Blood Anatomy 0.000 description 2
- 229930006649 D-Glucose Natural products 0.000 description 2
- 229920002307 Dextran Polymers 0.000 description 2
- 210000003141 Lower Extremity Anatomy 0.000 description 2
- 229960005356 Urokinase Drugs 0.000 description 2
- 102000003990 Urokinase-type plasminogen activator Human genes 0.000 description 2
- 108090000435 Urokinase-type plasminogen activator Proteins 0.000 description 2
- 210000003462 Veins Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 239000008522 danhong Substances 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 229940095529 heparin calcium Drugs 0.000 description 2
- 235000008216 herbs Nutrition 0.000 description 2
- 239000003055 low molecular weight heparin Substances 0.000 description 2
- 230000003285 pharmacodynamic Effects 0.000 description 2
- 230000002335 preservative Effects 0.000 description 2
- 239000003755 preservative agents Substances 0.000 description 2
- 210000004204 Blood Vessels Anatomy 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000004745 nonwoven fabrics Substances 0.000 description 1
- 230000001737 promoting Effects 0.000 description 1
- 230000002522 swelling Effects 0.000 description 1
- 239000004577 thatch Substances 0.000 description 1
- 230000001732 thrombotic Effects 0.000 description 1
- 230000036269 ulceration Effects 0.000 description 1
Abstract
Description
Technical field
The present invention relates to one and be used for the treatment of phlebitic Traditional Chinese Medicine for external application preparation.
Background technology
Along vein, move towards to occur that red, swollen, hot, pain is phlebitic main clinical manifestation, phlebitic generation is common with person between twenty and fifty clinically, to patient, has brought painful and very large inconvenience.At present, the phlebitic method of traditional treatment: 5% glucose 250ml+ DANHONG ZHUSHEYE 20.00 ml ivdrip qd, low molecular dextran 30.00g ivdrip qd, low molecular heparin calcium 5000.00iu ih, every day 3-4 time (according to the state of an illness), (10-20 ten thousand is ivdrip qd u) if any thrombosis, to add use NS500ml+ urokinase again.It is just very painful that patient has suffered from phlebitis, and play pin several times every day again, and this has increased misery to patient again, a lot of patients, and therapeutic effect is also not good, repeatedly outbreak.
Summary of the invention
The object of this invention is to provide one and be used for the treatment of phlebitic Traditional Chinese Medicine for external application preparation.
For achieving the above object, the technical solution used in the present invention is:
A kind of phlebitis Traditional Chinese Medicine for external application preparation, is characterized in that: the raw material of Chinese medicine that comprises following parts by weight is made:
Radix Notoginseng 5～20; Radix Salviae Miltiorrhizae 5～15; Rhizoma Corydalis 10～30; Radix Angelicae Sinensis 5～30; Radix Curcumae 10～30; Rhizoma Curcumae 5～25; Semen Persicae 15～30; Flos Carthami 15～30; Herba Lycopi 15～30; Olibanum 8～15; Myrrha 8～15; Rhizoma Corydalis 10～20; King does not stay 15～30; Radix Paeoniae Rubra 10～25; Radix Achyranthis Bidentatae 8～20; Rhizoma Chuanxiong 12～20; Rhizoma Curcumae Longae 15～30; Lignum Sappan 10～30.
According to described phlebitis Traditional Chinese Medicine for external application preparation, it is characterized in that: the raw material of Chinese medicine that increases following weight portion on the basis by described raw material of Chinese medicine is made:
Cortex Moutan 8～20; Radix Arnebiae (Radix Lithospermi) 10～30; Flos Campsis 5～25; Ramulus Euonymi 5～25; Caulis Sargentodoxae 15～30; Rhizoma Polygoni Cuspidati 15～30; Herba Patriniae 10～30; Rhizoma Fagopyri Dibotryis 15～30.
According to described phlebitis Traditional Chinese Medicine for external application preparation, it is characterized in that: described several raw material of Chinese medicine weight portions are:
Radix Notoginseng 10; Radix Salviae Miltiorrhizae 15; Rhizoma Corydalis 15; Radix Angelicae Sinensis 15; Radix Curcumae 10; Rhizoma Curcumae 10; Semen Persicae 16; Flos Carthami 18; Herba Lycopi 16; Olibanum 10; Myrrha 12; Rhizoma Corydalis 15; King does not stay 20; Radix Paeoniae Rubra 12; Radix Achyranthis Bidentatae 15; Rhizoma Chuanxiong 20; Rhizoma Curcumae Longae 15; Lignum Sappan 18.
According to described phlebitis Traditional Chinese Medicine for external application preparation, it is characterized in that: the heavy amount part of described several raw material of Chinese medicine is:
Radix Notoginseng 10; Radix Salviae Miltiorrhizae 15g; Rhizoma Corydalis 15; Radix Angelicae Sinensis 15; Radix Curcumae 10; Rhizoma Curcumae 10; Semen Persicae 15; Flos Carthami 20; Herba Lycopi 16; Olibanum 12g; Myrrha 12; Rhizoma Corydalis 15; King does not stay 20; Radix Paeoniae Rubra 10; Radix Achyranthis Bidentatae 15; Rhizoma Chuanxiong 15; Rhizoma Curcumae Longae 20; Lignum Sappan 20.
According to described phlebitis Traditional Chinese Medicine for external application preparation, it is characterized in that: described several raw material of Chinese medicine weight portions are:
Radix Notoginseng 10; Radix Salviae Miltiorrhizae 15; Rhizoma Corydalis 15; Radix Angelicae Sinensis 15; Radix Curcumae 10; Rhizoma Curcumae 18; Semen Persicae 16; Flos Carthami 20; Herba Lycopi 16g; Olibanum 9; Myrrha 9; Rhizoma Corydalis 15; King does not stay 20; Radix Paeoniae Rubra 10; Radix Achyranthis Bidentatae 15; Rhizoma Chuanxiong 15; Rhizoma Curcumae Longae 15; Lignum Sappan 18.
According to described phlebitis Traditional Chinese Medicine for external application preparation, it is characterized in that: described several raw material of Chinese medicine weight portions are:
Radix Notoginseng 10; Radix Salviae Miltiorrhizae 15; Rhizoma Corydalis 15; Radix Angelicae Sinensis 15; Radix Curcumae 10; Rhizoma Curcumae 10; Semen Persicae 16; Flos Carthami 18; Herba Lycopi 16; Olibanum 10; Myrrha 12; Rhizoma Corydalis 15; King does not stay 20; Radix Paeoniae Rubra 12; Radix Achyranthis Bidentatae 15; Rhizoma Chuanxiong 20; Rhizoma Curcumae Longae 15; Lignum Sappan 18; Cortex Moutan 10; Radix Arnebiae (Radix Lithospermi) 15; Flos Campsis 12g; Ramulus Euonymi 16; Caulis Sargentodoxae 15; Rhizoma Polygoni Cuspidati 18; Herba Patriniae 15; Rhizoma Fagopyri Dibotryis 18.
According to described phlebitis Traditional Chinese Medicine for external application preparation, it is characterized in that: described several raw material of Chinese medicine weight portions are:
Radix Notoginseng 10; Radix Salviae Miltiorrhizae 15; Rhizoma Corydalis 15; Radix Angelicae Sinensis 15; Radix Curcumae 10; Rhizoma Curcumae 10; Semen Persicae 15; Flos Carthami 20; Herba Lycopi 16; Olibanum 12g; Myrrha 12; Rhizoma Corydalis 15; King does not stay 20; Radix Paeoniae Rubra 10; Radix Achyranthis Bidentatae 15; Rhizoma Chuanxiong 15; Rhizoma Curcumae Longae 20; Lignum Sappan 20; Cortex Moutan 12; Radix Arnebiae (Radix Lithospermi) 10; Flos Campsis 15; Ramulus Euonymi 16; Caulis Sargentodoxae 18; Rhizoma Polygoni Cuspidati 20; Herba Patriniae 18; Rhizoma Fagopyri Dibotryis 15.
According to described phlebitis Traditional Chinese Medicine for external application preparation, it is characterized in that: described several raw material of Chinese medicine weight portions are:
Radix Notoginseng 10; Radix Salviae Miltiorrhizae 15; Rhizoma Corydalis 15; Radix Angelicae Sinensis 15; Radix Curcumae 10; Rhizoma Curcumae 18; Semen Persicae 16; Flos Carthami 20; Herba Lycopi 16; Olibanum 9; Myrrha 9; Rhizoma Corydalis 15; King does not stay 20; Radix Paeoniae Rubra 10; Radix Achyranthis Bidentatae 15; Rhizoma Chuanxiong 15; Rhizoma Curcumae Longae 15; Lignum Sappan 18; Cortex Moutan 18; Radix Arnebiae (Radix Lithospermi) 18; Flos Campsis 15; Ramulus Euonymi 15; Caulis Sargentodoxae 16; Rhizoma Polygoni Cuspidati 16; Herba Patriniae 25; Rhizoma Fagopyri Dibotryis 20.
The present invention avoids increasing misery to patient, can treat again disease, for phlebitis patient 60 examples, and with the same period patient 60 example with traditional Therapeutic Method, compare.Through observing contrast, result confirms: phlebitis Traditional Chinese Medicine for external application preparation of the present invention is respond well, has no side effect, and patient is very satisfied, has alleviated the misery that phlebitis and traditional Therapeutic Method bring to patient, and therapeutic effect is good.Phlebitis Traditional Chinese Medicine for external application preparation of the present invention has following beneficial effect: 1, evident in efficacy to phlebitic treatment, treat safe and reliablely, and have no side effect.2, the comfort level that has improved patient, has reduced relapse rate.3, expense is low, has alleviated patient's financial burden.4, simple to operate, economical and practical.5, good economic benefit and social benefit have been obtained.
The specific embodiment
Below in conjunction with specific embodiment, the invention will be further described:
one, phlebitis Traditional Chinese Medicine for external application preparation raw material of Chinese medicine weight proportion of the present invention is:
Radix Notoginseng (5～20 grams); Radix Salviae Miltiorrhizae (5～15g); Rhizoma Corydalis (10～30g); Radix Angelicae Sinensis (5～30g); Radix Curcumae (10～30g); Rhizoma Curcumae (5～25g); Semen Persicae (15～30g); Flos Carthami (15～30g); Herba Lycopi (15～30g); Olibanum (8～15g); Myrrha (8～15g); Rhizoma Corydalis (10～20g); King does not stay (15～30g); Radix Paeoniae Rubra (10～25g); Radix Achyranthis Bidentatae (8～20g); Rhizoma Chuanxiong (12～20g); Rhizoma Curcumae Longae (15～30g); Lignum Sappan (10～30g).
Embodiment 1
Phlebitis Traditional Chinese Medicine for external application preparation raw material of Chinese medicine proportioning weight of the present invention is:
Radix Notoginseng (10 grams); Radix Salviae Miltiorrhizae (15g); Rhizoma Corydalis (15g); Radix Angelicae Sinensis (15g); Radix Curcumae (10g); Rhizoma Curcumae (10g); Semen Persicae (16g); Flos Carthami (18g); Herba Lycopi (16g); Olibanum (10g); Myrrha (12g); Rhizoma Corydalis (15g); King does not stay (20g); Radix Paeoniae Rubra (12g); Radix Achyranthis Bidentatae (15g); Rhizoma Chuanxiong (20g); Rhizoma Curcumae Longae (15g); Lignum Sappan (18g).
Olibanum, Myrrha, Radix Salviae Miltiorrhizae, Rhizoma Corydalis, Radix Paeoniae Rubra, Radix Achyranthis Bidentatae, Semen Vaccariae, Rhizoma Chuanxiong, Radix Angelicae Sinensis, Radix Curcumae, Rhizoma Curcumae Longae, Lignum Sappan etc. in the present invention, have the effect of sedation-analgesia, is used for the treatment of take pain as main phlebitis.
Embodiment 2 (most preferred embodiment )
Phlebitis Traditional Chinese Medicine for external application preparation raw material of Chinese medicine weight proportion of the present invention is:
Radix Notoginseng (10 grams); Radix Salviae Miltiorrhizae (15g); Rhizoma Corydalis (15g); Radix Angelicae Sinensis (15g); Radix Curcumae (10g); Rhizoma Curcumae (10g); Semen Persicae (15g); Flos Carthami (20g); Herba Lycopi (16g); Olibanum (12g); Myrrha (12g); Rhizoma Corydalis (15g); King does not stay (20g); Radix Paeoniae Rubra (10g); Radix Achyranthis Bidentatae (15g); Rhizoma Chuanxiong (15g); Rhizoma Curcumae Longae (20g); Lignum Sappan (20g).
In the present invention, Rhizoma Curcumae Longae, Radix Salviae Miltiorrhizae, Olibanum, Myrrha, Lignum Sappan, Flos Carthami etc. have the effect of blood circulation promoting and blood stasis dispelling, reducing swelling and alleviating pain, for the phlebitis of red, swollen and pain.
Embodiment 3
Phlebitis Traditional Chinese Medicine for external application preparation raw material of Chinese medicine weight of the present invention is:
Radix Notoginseng (10 grams); Radix Salviae Miltiorrhizae (15g); Rhizoma Corydalis (15g); Radix Angelicae Sinensis (15g); Radix Curcumae (10g); Rhizoma Curcumae (18g); Semen Persicae (16g); Flos Carthami (20g); Herba Lycopi (16g); Olibanum (9g); Myrrha (9g); Rhizoma Corydalis (15g); King does not stay (20g); Radix Paeoniae Rubra (10g); Radix Achyranthis Bidentatae (15g); Rhizoma Chuanxiong (15g); Rhizoma Curcumae Longae (15g); Lignum Sappan (18g).
In the present invention, Rhizoma Curcumae, Semen Persicae have the effect of removing blood stasis eliminating stagnation, very good to there being thrombotic phlebitis effect.
when two, the present invention has ulceration, suppuration for phlebitis, then add in order to lower raw material of Chinese medicine (weight):
Cortex Moutan (8～20g); Radix Arnebiae (Radix Lithospermi) (10～30g); Flos Campsis (5～25g); Ramulus Euonymi (5～25g); Caulis Sargentodoxae (15～30g); Rhizoma Polygoni Cuspidati (15～30g); Herba Patriniae (10～30g); Rhizoma Fagopyri Dibotryis (15～30g).
Embodiment 4
Raw material of Chinese medicine proportioning is:
Radix Notoginseng (10 grams); Radix Salviae Miltiorrhizae (15g); Rhizoma Corydalis (15g); Radix Angelicae Sinensis (15g); Radix Curcumae (10g); Rhizoma Curcumae (10g); Semen Persicae (16g), Flos Carthami (18g), Herba Lycopi (16g), Olibanum (10g), Myrrha (12g), Rhizoma Corydalis (15g), Wang Buliu (20g); Radix Paeoniae Rubra (12g); Radix Achyranthis Bidentatae (15g); Rhizoma Chuanxiong (20g); Rhizoma Curcumae Longae (15g); Lignum Sappan (18g); Cortex Moutan (10g); Radix Arnebiae (Radix Lithospermi) (15g); Flos Campsis (12g); Ramulus Euonymi (16g); Caulis Sargentodoxae (15g); Rhizoma Polygoni Cuspidati (18g); Herba Patriniae (15g); Rhizoma Fagopyri Dibotryis (18g).
Embodiment 5
Raw material of Chinese medicine proportioning is:
Radix Notoginseng (10 grams); Radix Salviae Miltiorrhizae (15g); Rhizoma Corydalis (15g); Radix Angelicae Sinensis (15g); Radix Curcumae (10g); Rhizoma Curcumae (10g); Semen Persicae (15g); Flos Carthami (20g); Herba Lycopi (16g); Olibanum (12g); Myrrha (12g); Rhizoma Corydalis (15g); King does not stay (20g); Radix Paeoniae Rubra (10g); Radix Achyranthis Bidentatae (15g); Rhizoma Chuanxiong (15g); Rhizoma Curcumae Longae (20g); Lignum Sappan (20g); Cortex Moutan (12g); Radix Arnebiae (Radix Lithospermi) (10g); Flos Campsis (15g); Ramulus Euonymi (16g); Caulis Sargentodoxae (18g); Rhizoma Polygoni Cuspidati (20g); Herba Patriniae (18g); Rhizoma Fagopyri Dibotryis (15g).
Embodiment 6
Raw material of Chinese medicine proportioning is:
Radix Notoginseng (10 grams); Radix Salviae Miltiorrhizae (15g); Rhizoma Corydalis (15g); Radix Angelicae Sinensis (15g); Radix Curcumae (10g); Rhizoma Curcumae (18g); Semen Persicae (16g); Flos Carthami (20g); Herba Lycopi (16g); Olibanum (9g); Myrrha (9g); Rhizoma Corydalis (15g); King does not stay (20g); Radix Paeoniae Rubra (10g); Radix Achyranthis Bidentatae (15g); Rhizoma Chuanxiong (15g); Rhizoma Curcumae Longae (15g); Lignum Sappan (18g); Cortex Moutan (18g); Radix Arnebiae (Radix Lithospermi) (18g); Flos Campsis (15g); Ramulus Euonymi (15g); Caulis Sargentodoxae (16g); Rhizoma Polygoni Cuspidati (16g); Herba Patriniae (25g); Rhizoma Fagopyri Dibotryis (20g).
three, manufacture method:
After above prescription is pulverized, pack in packaging bag, bag material is selected cotton or non-woven fabrics.Large, medium and small three kinds of models are made in packaging bag, and existing take medium size as example, packaging bag is long × wide is 25 × 15cm.
four, using method:
During the sack that packs medicine into is discharged water, after big fire is boiled, change and simmer in water 10～15 minutes, pull out, temperature is suitable by the time, spreads on phlebitis place, notes avoiding scalding.As low in medicated bag temperature, medicated bag can be put back in the water of original decoct medicinal herbs bag again and be heated, also can cover on medicated bag with preservative film, on preservative film, with 50 ℃ of left and right hot water bag, apply 15～30 minutes.Hot compress every day 3 times, each 20～30 minutes.The water of decoct medicinal herbs can be used for foot bath, drench lower limb.
five, pharmacodynamics test statistics:
The present invention carries out pharmacodynamics test with the raw material of Chinese medicine proportioning of embodiment 2 .
The present invention is for phlebitis patient 60 examples, and with the same period patient's 60 examples with traditional Therapeutic Method, compare.Through observing contrast, result confirms: phlebitis Traditional Chinese Medicine for external application preparation is respond well, has no side effect, and patient is very satisfied, has alleviated the misery that phlebitis and traditional Therapeutic Method bring to patient, and therapeutic effect is good.Now be reported as follows.
Physical data:
Object of study is totally 120 examples (being the phlebitis of lower extremities), by randomized principle, is divided into observation group and matched group.Observation group's 60 examples, male 48 examples, female's 12 examples; Matched group 60 examples, male 43 examples, female's 17 examples.Age: observation group, 21～75 years old, average 42.22 ± 10.60 years old; Matched group, 19～71 years old, average 39.82 ± 9.76 years old.Disease time: the 3h～15d of observation group, average 6.5d; Matched group 4h～12d, average 4.8d; Occupation: observation group, workman's 30 examples, cadre's 21 examples, peasant's 9 examples.Matched group, workman's 31 examples, cadre's 22 examples, peasant's 7 examples.
Two groups of patients' age, disease time, occupation are carried out to t check, and result shows the equal not statistically significant of difference (p>0.05), and two groups have comparability.
Diagnostic criteria:
1, along superficial vein, move towards to occur phlebitis red, hot, pain.
2, B ultrasonic shows: without thrombosis, and the rough phlebitis of blood vessel wall thatch.
3, B ultrasonic shows: there is thrombosis, and with phlebitis hot, swollen, pain.
Therapeutic Method:
Observation group is used a course for the treatment of of Chinese medicine preparation of the present invention (14 days), observe the curative effect; Matched group adopts the phlebitic method of traditional treatment: 5% glucose 250ml+ DANHONG ZHUSHEYE 20.00 ml ivdrip qd, low molecular dextran 30.00g ivdrip qd, (10-20 ten thousand is ivdrip qd u) for NS500ml+ urokinase, low molecular heparin calcium 5000.00iu ih, every day 3 times, treat a course for the treatment of (within 14th, being a course for the treatment of), observe 7 days and one the course for the treatment of curative effect.
Therapeutic outcome:
The effect comparison in 7 days of two groups of patient treatments, the results are shown in Table 1.
Table 1 liang group patient treatment effect comparison in 7 days
Note: X 2=35.29, P < 0.01, through treatment in 7 days, two groups of curative effects had highly significant difference.
Apply Chinese medicine preparation treatment phlebitis of the present invention 60 examples, through treatment in 7 days, cure 26 examples, 32 examples that take a turn for the better, invalid 2 examples, cure rate 43%, total effective rate 96%, learns by statistics and processes (X 2check), observation group's curative effect is apparently higher than matched group (P<0.01).
Through therapeutic effect comparison in 14 days, the results are shown in Table 2.
Table 2 liang group patient treatment effect comparison in 14 days
Note: X 2=12.04, P < 0.01, through treatment in 14 days, two groups of curative effects had highly significant difference.
Through treatment in 14 days, observe, treatment group is always cured 54 examples, 6 examples that take a turn for the better, and cure rate 90%, total effective rate 100%, learns by statistics and processes (X 2check), observation group's curative effect is apparently higher than matched group (P<0.01).
Two groups of patient's comfort level comparisons during treating, the results are shown in Table 3.
Table 3 liang group patient's comfort level comparison during treating (example, percentage ratio %)
Note: X 2 =108.93, p < 0.01,two groups of patients comfort level during treating relatively has highly significant difference.
Apply Chinese medicine preparation treatment phlebitis of the present invention 60 examples, during treatment, comfortable person's 56 examples, more comfortable person's 4 examples, without uncomfortable person, learn by statistics and process (X 2 check), observation group's comfort level is apparently higher than matched group (P<0.01).
Treatment conclusion (advantage):
Phlebitis Traditional Chinese Medicine for external application preparation of the present invention, 1, evident in efficacy to phlebitic treatment, treat safe and reliablely, have no side effect.2, the comfort level that has improved patient, has reduced relapse rate.3, expense is low, has alleviated patient's financial burden.4, simple to operate, economical and practical.5, good economic benefit and social benefit have been obtained.
Claims (4)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310074393.6A CN103127463B (en) | 2013-03-09 | 2013-03-09 | External Chinese medicine preparation for phlebophlogosis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310074393.6A CN103127463B (en) | 2013-03-09 | 2013-03-09 | External Chinese medicine preparation for phlebophlogosis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103127463A CN103127463A (en) | 2013-06-05 |
| CN103127463B true CN103127463B (en) | 2014-05-07 |
Family
ID=48488333
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310074393.6A CN103127463B (en) | 2013-03-09 | 2013-03-09 | External Chinese medicine preparation for phlebophlogosis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103127463B (en) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103768397B (en) * | 2014-02-27 | 2016-01-20 | 青岛市市立医院 | A kind of medicine for external use for the treatment of the mechanical phlebitis that peripheral central vein retaining tube causes |
| CN104288672A (en) * | 2014-09-09 | 2015-01-21 | 青岛市市立医院 | Traditional Chinese medicine composition for treating phlebophlogosis and preparation method thereof |
| CN105169261A (en) * | 2015-09-24 | 2015-12-23 | 余晓燕 | Plaster for treating phlebitis |
| CN105770534A (en) * | 2016-03-31 | 2016-07-20 | 山东大学齐鲁医院 | External medicine for treating infusion phlebitis |
| CN107096094A (en) * | 2017-07-07 | 2017-08-29 | 李宝 | A kind of delay pin with function promoting blood circulation and removing blood stasis fixes adhesive plaster |
Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1151875A (en) * | 1995-12-14 | 1997-06-18 | 北京海尔富药业有限公司 | Chinese medicine prepn |
| CN101152406A (en) * | 2006-09-30 | 2008-04-02 | 毕庆双 | Externally applied medicine for treating varicosity and phlebitis |
| CN101455727A (en) * | 2007-12-12 | 2009-06-17 | 天津市中宝制药有限公司 | External application agent for treating phlebitis |
| CN101607000A (en) * | 2009-02-14 | 2009-12-23 | 房笑丽 | Seven the flavor promote blood circulation hot application and to the transfusion induced phlebitis control |
| CN101647870A (en) * | 2009-09-11 | 2010-02-17 | 李红 | Traditional Chinese medicine for treating phlebitis caused by chemotherapeutics |
| CN102671054A (en) * | 2012-06-12 | 2012-09-19 | 赵国藏 | Traditional Chinese medicine composition for treating thrombophlebitis |
| CN102727641A (en) * | 2012-07-13 | 2012-10-17 | 孙红梅 | External traditional Chinese medicine for treating superficial phlebitis |
-
2013
- 2013-03-09 CN CN201310074393.6A patent/CN103127463B/en not_active IP Right Cessation
Patent Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1151875A (en) * | 1995-12-14 | 1997-06-18 | 北京海尔富药业有限公司 | Chinese medicine prepn |
| CN101152406A (en) * | 2006-09-30 | 2008-04-02 | 毕庆双 | Externally applied medicine for treating varicosity and phlebitis |
| CN101455727A (en) * | 2007-12-12 | 2009-06-17 | 天津市中宝制药有限公司 | External application agent for treating phlebitis |
| CN101607000A (en) * | 2009-02-14 | 2009-12-23 | 房笑丽 | Seven the flavor promote blood circulation hot application and to the transfusion induced phlebitis control |
| CN101647870A (en) * | 2009-09-11 | 2010-02-17 | 李红 | Traditional Chinese medicine for treating phlebitis caused by chemotherapeutics |
| CN102671054A (en) * | 2012-06-12 | 2012-09-19 | 赵国藏 | Traditional Chinese medicine composition for treating thrombophlebitis |
| CN102727641A (en) * | 2012-07-13 | 2012-10-17 | 孙红梅 | External traditional Chinese medicine for treating superficial phlebitis |
Also Published As
| Publication number | Publication date |
|---|---|
| CN103127463A (en) | 2013-06-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102961729B (en) | Externally-used traditional Chinese medicine for treating varicosity, thromboangiitis obliterans and phlebitis | |
| CN102319327B (en) | Traditional Chinese medicine for internally and externally treating diabetic foot | |
| CN101167840B (en) | Medicinal composition for treating burns and scald and its preparation method | |
| CN101209337B (en) | Medicinal liquor for treating rheumatism and rheumatoid | |
| CN102488879B (en) | Medicinal composition for treating rheumatism | |
| CN102091203A (en) | External traditional Chinese medicine preparation for treating chronic wounds and preparation method thereof | |
| CN103212040B (en) | Chinese medicinal composition for treatment of seborrheic alopecia | |
| CN102847157B (en) | Traditional Chinese medicine composition for treating nephropathy through targeted transferring in renal region | |
| CN104398718A (en) | Plaster for treating pains in neck, shoulder, waist and legs, and making method thereof | |
| CN103071128B (en) | Externally-applied plaster for curing dysmenorrhea | |
| CN101810685A (en) | Chinese medicinal composition for treating gonitis and preparation method thereof | |
| CN103341145B (en) | Traditional Chinese medicine for treating psoriasis and preparation method thereof | |
| CN101766773A (en) | Chinese medicine prescription for treating talagia | |
| CN101347536B (en) | External-use preparation for treating traumatic injury | |
| CN103751497A (en) | Medicament for treating mastitis and preparation method thereof | |
| CN104666951A (en) | Traditional Chinese medicine composition for treating parturient paresis puerperal fever | |
| CN100998838A (en) | Chinese medicine for relaxing muscles and tendons to promote blood circulation preparation method thereof | |
| CN104127618A (en) | Plaster for treating heumatism | |
| CN101810835A (en) | Chinese medicinal composition for treating purpura and preparation method thereof | |
| CN101700386B (en) | Traditional Chinese medicine composition resistant to liver cancer and medicine coat thereof | |
| CN102327588A (en) | Method for preparing traditional Chinese medicine (TCM) lotion for treating anorexia bedsore | |
| CN101757313B (en) | Liquid medicine | |
| CN104383390A (en) | Chinese traditional medicine preparation for treating lung cancer | |
| CN102000164B (en) | Traditional Chinese medicine composition for treating psoriasis and preparation method thereof | |
| CN102178800B (en) | Chinese medicine composition for treating rheumatoid arthritis and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C41 | Transfer of patent application or patent right or utility model | ||
| C53 | Correction of patent for invention or patent application | ||
| ASS | Succession or assignment of patent right |
Owner name: ZAOZHUANG MUNICIPAL HOSPITAL Free format text: FORMER OWNER: NIU YULING Effective date: 20140409 |
|
| COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: NIU YULING YU QINQIN TO: NIU YULING YU QINQIN JIANG JIFANG XIE XIAOHONG LIU CHANGRUI NIU XINYI |
|
| TA01 | Transfer of patent application right |
Effective date of registration: 20140409 Address after: 277100, No. 41, bibcock Road, Shizhong District, Shandong, Zaozhuang Applicant after: ZAOZHUANG MUNICIPAL HOSPITAL Address before: Department of general surgery, Zaozhuang municipal hospital, 41 leading Road, Shizhong District, Shandong, Zaozhuang 277100, China Applicant before: Niu Yuling |
|
| CB03 | Change of inventor or designer information |
Inventor after: Niu Yuling Inventor after: Yu Qinqin Inventor after: Jiang Jifang Inventor after: Xie Xiaohong Inventor after: Liu Changrui Inventor after: Niu Xinyi Inventor before: Niu Yuling Inventor before: Yu Qinqin |
|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20140507 Termination date: 20170309 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |